Tenders/[Z115176W] Autologous CIK Cell Therapy for Solid Tumors Stages I-IV Two-Year Open Contract

Open🇹🇼TaiwanServices4 days remaining

[Z115176W] Autologous CIK Cell Therapy for Solid Tumors Stages I-IV Two-Year Open Contract

Auto-translated from Chinese

Original title: [Z115176W] 自體免疫CIK細胞治療實體癌第一至四期兩年開口契約

臺北榮民總醫院

Published: Jun 18, 2026

Updated: Jun 25, 2026

Source: taiwan_pcc

About This Opportunity

This is a services contract in the health and medical services and Research sectors, with a focus on Vaccines. Located in Taiwan, Asia, this opportunity is open to firms and consortiums, with an estimated budget of TWD 18.9 million. Proposals must be submitted before June 30, 2026.

Published through Taiwan PCC e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

This tender, originating from Taipei Veterans General Hospital (臺北榮民總醫院) in Taiwan, is for specialized medical services. The project entails an 'Open Contract for Two-Year Autologous Immune Effector Cell (CIK) Therapy for Solid Tumors in Clinical Phase I to IV' (自體免疫CIK細胞治療實體癌第一至四期兩年開口契約). The procurement nature is 'Services' (勞務類), focusing on advanced medical treatment. The tender method is 'Public Tender' (公開招標), indicating a formal competitive process for selecting a service provider. The significant budget allocated for this two-year contract is NT$18,900,000. Typical requirements for such a tender would include stringent qualifications for the healthcare provider, such as relevant certifications, extensive experience in administering CIK cell therapy, adherence to Good Manufacturing Practices (GMP) for cell processing, robust patient safety protocols, and a proven track record in managing clinical trials or advanced therapies. The contract will likely specify the number of patients to be treated, the treatment protocols, monitoring requirements, and reporting obligations. The hospital seeks a reliable partner to provide cutting-edge cancer treatment options, ensuring the highest standards of patient care and clinical efficacy. Evaluation will heavily weigh clinical expertise, safety records, and the proposed service delivery model.

Data provenance

This notice is sourced from Taiwan PCC e-Procurement and was originally published on June 18, 2026. Last refreshed 1 day ago. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 臺北榮民總醫院

臺北榮民總醫院 has issued 742 procurement notices on BidsFactory, including 123 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Taiwan. Notices are distributed via Taiwan PCC e-Procurement. Most recent publication: June 18, 2026.

Frequently asked questions about this tender

What is the estimated budget?

The estimated contract value is NT$18,900,000 - NT$18,900,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Taiwan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Taiwan PCC e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is June 30, 2026. You have 4 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by 臺北榮民總醫院 in Taiwan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.